Journal
/
/
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
DOI:

06:08 min

February 10, 2023

, , , , , , , ,

Chapters

  • 00:04Introduction
  • 00:49Assessment of CART19 Cell‐Associated Toxicities
  • 01:33MRI Imaging
  • 04:02Results: Assessment of CART Cell‐Associated Toxicities in a PDX Mice Model
  • 05:17Conclusion

Summary

Automatic Translation

Here, we describe a protocol in which an acute lymphoblastic leukemia patient-derived xenograft model is used as a strategy to assess and monitor CD19-targeted chimeric antigen receptor T cell-associated toxicities.

Related Videos

Read Article